scorecardresearch
US pharma giant Gilead uses ‘Double Irish’ tax loophole where to buy illegal steroids online the truth about anabolic steroids and its relation to health and fitness | fit for the soul

Dr Reddy’s completes Fondaparinux IP purchase

The company had signed a term sheet for this transaction with its Australian partner, Alchemia in September 2015

The company had signed a term sheet for this transaction with its Australian partner, Alchemia in September 2015

Dr Reddy’s Laboratories has completed the purchase of worldwide exclusive intellectual property (IP) rights for Fondaparinux sodium, its generic anti-coagulant drug from its Australian partner, Alchemia. Earlier, the company had signed a term sheet for this transaction in September, 2015.

Alchemia’s shareholders approved the sale of Fondaparinux at the company’s annual general meeting held recently, post which Dr Reddy’s and Alchemia have executed a purchase and sale agreement, together with various patent assignment deeds. Alchemia has received $17.5 million from Dr Reddy’s as consideration for the sale. The agreement is effective July 2015.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Most Read In Latest Updates